Key facts
- Cogniss’s last known valuation is $12.0M (Dec 2021).
- It has raised $1.1M; the latest was Later Stage VC in Apr 2025.
- Notable investors include Blackfinch Ventures.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Cogniss
- ·The full record, as it builds
Funding rounds
No funding rounds for Cogniss are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Cogniss
Developer of a no-code platform designed to create advanced patient-facing digital health applications. The company's platform offers a point-and-click interface and develops games and software products to provide technological services for education, health, business, games, simulation, and others, enabling healthcare experts and organizations to build highly customized applications faster and at a lower cost than traditional code-based development.
- Sector
- Information Technology
- HQ
- Cambridge, United Kingdom
- Founded
- 2007
- Employees
- 40
- Website
- cogniss.com/
- Ownership
- Privately Held (backing)
Cogniss doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Cogniss shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Cogniss in its N-PORT filings yet. We sweep new filings monthly.